Edap TMS SA (FOCL)
- Sector
- Healthcare
- Industry
- Medical Distribution
- Last price
- $4.17
- As of
Kresmion compiles this page from FOCL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
EDAP TMS SA (FOCL): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-19.
See the full FOCL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for FOCL on one page. Preview it with sample data, then open it live with a free account.
Preview the FOCL dossierActive signals for FOCL
- mediumEarnings below estimates
Q2-2026: Missed consensus by 68.6%, EPS $-0.3905 vs $-0.2316 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 81% of FOCL (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +59% to FOCL (2026Q2)
FREE, NO ACCOUNT
Every signal on FOCL, as it fires
New filings, 13F moves and cross asset signals on FOCL land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in FOCL (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 268311107 · 2026Q2 | $343K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, FOCL
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
FOCL against its peers
FOCL's operating margin of -35.0% ranks in the 31st percentile of 7 Medical Distribution sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-04-30.
| Metric | FOCL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 70.5M USD | 21.8M USD | 93 | 6 |
| Gross margin | 42.5% | 11.9% | 81 | 7 |
| Operating margin | -35.0% | -25.6% | 31 | 7 |
| Net margin | -41.5% | -29.3% | 31 | 7 |
| Return on equity | -150.7% | n/a | n/a | 4 |
Peers (7): VNOV, COSM, YI, AHG, MEDS, HKPD, SNYRQ. Left out: EMPG.D (no annual filing), EXHI (no annual filing), EBOSY (no annual filing), GEGP (no annual filing). Fiscal periods ending between 2025-03-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (FOCL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow FOCL on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to FOCL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.